{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:29:17Z","timestamp":1770038957056,"version":"3.49.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mbc.0b013e328358e8e7","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T07:40:58Z","timestamp":1353570058000},"page":"85-89","source":"Crossref","is-referenced-by-count":13,"title":["Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies"],"prefix":"10.1097","volume":"24","author":[{"given":"Hiroyuki","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210203","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000084241","article-title":"Extracellular transglutaminase: factor XIII.","volume":"38","author":"Ichinose","year":"2005","journal-title":"Prog Exp Tumor Res"},{"key":"R2-15-20210203","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"key":"R3-15-20210203","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH10-11-0724","article-title":"Japanese collaborative research group on Acquired haemorrha-philia due to factor XIII deficiencyAs many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.","volume":"105","author":"Ichinose","year":"2011","journal-title":"Thromb Haemost"},{"key":"R4-15-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0031-1276587","article-title":"Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited.","volume":"37","author":"Ichinose","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R5-15-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-0734.2001.00049.x","article-title":"Acquired hemophilia.","volume":"5","author":"Boggio","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"R6-15-20210203","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"for the UK Haemophilia Centre Doctors OrganisationAcquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors Organisation.","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"R7-15-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12185-011-0992-7","article-title":"Reduced difference of (2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to antifactor XIII antibodies.","volume":"55","author":"Ichinose","year":"2012","journal-title":"Int J Hematol"},{"key":"R8-15-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12185-007-0005-z","article-title":"Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.","volume":"87","author":"Souri","year":"2008","journal-title":"Int J Hematol"},{"key":"R9-15-20210203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Education Committee of the Academy of Clinical Laboratory Physicians and ScientistsPathology consultation on drug-induced hemolytic anemia.","volume":"136","author":"Pierce","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R10-15-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy.","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev"},{"key":"R11-15-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.seminhematol.2005.04.004","article-title":"The changing spectrum of drug-induced immune hemolytic anemia.","volume":"42","author":"Arndt","year":"2005","journal-title":"Semin Hematol"},{"key":"R12-15-20210203","first-page":"639","article-title":"Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstroms macroglobulinemia.","volume":"90","author":"Krumdieck","year":"1991","journal-title":"Am J Med"},{"key":"R13-15-20210203","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1055\/s-0037-1616574","article-title":"Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin.","volume":"93","author":"Miesbach","year":"2005","journal-title":"Thromb Haemost"},{"key":"R14-15-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","article-title":"Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.","volume":"95","author":"Ichinose","year":"2012","journal-title":"Int J Hematol"},{"key":"R15-15-20210203","first-page":"e46","article-title":"Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.","volume":"89","author":"Nijenhuis","year":"2004","journal-title":"Haematologica"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-201301000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:13:18Z","timestamp":1618035198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201301000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328358e8e7","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}